Advertisement Simbionix and Johnson & Johnson's subsidiary sign distribution agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Simbionix and Johnson & Johnson’s subsidiary sign distribution agreement

Simbionix, a developer of medical simulation systems, has signed an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products.

Johnson & Johnson, LLC operates in Russia, Ukraine and CIS countries and is one of the subsidiaries of Johnson & Johnson.

Johnson & Johnson LLC will have exclusive rights to distribute Simbionix’s line of advanced medical simulators in hospitals in the Russia and CIS countries.

Gary Zamler, CEO of Simbionix, said: “We are very excited to enter into this collaboration with Johnson & Johnson LLC to bring our advanced simulators into the Russian republic’ hospitals, teaching facilities and interventional clinics. This agreement ushers in a new era of simulation-based training for Russia’s medical community and we envision beneficial for the countries covered by the agreement, Johnson & Johnson LLC and Simbionix.”